TOT Biopharm International Co (HKSE:01875) EPS (Basic) : HK$0.05 (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co EPS (Basic)?

TOT Biopharm International Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was HK$0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05.

TOT Biopharm International Co's EPS (Diluted) for the six months ended in Dec. 2024 was HK$0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05.

TOT Biopharm International Co's EPS without NRI for the six months ended in Dec. 2024 was HK$0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, TOT Biopharm International Co's highest 3-Year average EPS without NRI Growth Rate was 59.90% per year. The lowest was -39.90% per year. And the median was 24.60% per year.

TOT Biopharm International Co EPS (Basic) Historical Data

The historical data trend for TOT Biopharm International Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co EPS (Basic) Chart

TOT Biopharm International Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.61

-0.56

-0.09

-0.06

0.05

TOT Biopharm International Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial									-0.06	-0.02	-0.03	0.04	0.01

TOT Biopharm International Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

TOT Biopharm International Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(37.109	-	0)	/	725.197
	=	0.05

TOT Biopharm International Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3.414	-	0)	/	725.197
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.05

TOT Biopharm International Co (HKSE:01875) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

TOT Biopharm International Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

TOT Biopharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024

Website

https://www.totbiopharm.com.cn

TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families, as well as medical professionals. The company has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The company generates maximum revenues from Mainland China.

Executives

Center Laboratories, Inc.	2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited	2301 Trustee
Chengwei Evergreen Capital, Lp	2101 Beneficial owner
Center Laboratories Inc.	2101 Beneficial owner
Chengwei Evergreen Management, Llc	2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited	2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines